What is the price target for EDEN stock?
24 analysts have analysed EDEN.PA and the average price target is 25.95 EUR. This implies a price increase of 39.65% is expected in the next year compared to the current price of 18.58.
EPA:EDEN • FR0010908533
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EDENRED (EDEN.PA).
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 2.514B 23.78% | 2.856B 13.60% | 2.961B 3.68% | 2.971B 0.34% | 3.172B 6.77% | 3.406B 7.38% | 3.662B 7.52% | 3.541B -3.30% | |
| EBITDA YoY % growth | 1.247B 46.53% | 1.285B 3.05% | 1.337B 4.05% | 1.238B -7.40% | 1.348B 8.89% | 1.468B 8.90% | 1.582B 7.77% | 1.453B -8.15% | |
| EBIT YoY % growth | 901M 31.15% | 1.04B 15.43% | 1.048B 0.77% | 978.38M -6.64% | 1.056B 7.93% | 1.161B 9.94% | 1.29B 11.11% | 1.34B 3.88% | |
| Operating Margin | 35.84% | 36.41% | 35.39% | 32.93% | 33.29% | 34.09% | 35.23% | 37.84% | |
| EPS YoY % growth | 1.60 9.59% | 2.01 25.63% | N/A 13.17% | 2.07 -9.06% | 2.34 13.20% | 2.71 15.77% | 3.35 23.50% | 3.34 -0.14% |
All data in EUR
| Q4 / 25 | Q2 / 26 | Q4 / 26 | |
|---|---|---|---|
| EPS Q2Q % growth | 1.24 11.11% | 1.06 8.24% | 1.12 -10.25% |
| Revenue Q2Q % growth | 1.537B 3.35% | 1.456B 0.34% | 1.51B |
| EBITDA Q2Q % growth | 672.86M -15.58% | 628.83M -4.87% | 698.19M 3.76% |
| EBIT Q2Q % growth | 574.26M 4.03% | 504.39M -3.37% | 616.08M 7.28% |
All data in EUR
24 analysts have analysed EDEN.PA and the average price target is 25.95 EUR. This implies a price increase of 39.65% is expected in the next year compared to the current price of 18.58.
EDENRED (EDEN.PA) will report earnings on 2026-04-23.
The consensus EPS estimate for the next earnings of EDENRED (EDEN.PA) is 1.06 EUR and the consensus revenue estimate is 1.46B EUR.
The consensus rating for EDENRED (EDEN.PA) is 75.8333 / 100 . This indicates that analysts generally have a positive outlook on the stock.